Literature DB >> 6326224

Simple assessment of the nutritional status in the critically ill patient.

J M Boles, M A Garre, P Y Youinou.   

Abstract

The assessment of nutritional status in intensive care patients can be easily accomplished. The first step is to record the patient's complete medical and social history, and to perform a thorough clinical examination in search of signs of nutritional depletion. Several tests, simple and unexpensive, are available to assess the different compartments of the body such as: anthropometric measurements, weight, skinfold thickness and arm muscle circumference and area; biochemical assays, 24-h urinary excretion of creatinine and 3 methylhistidine, serum albumin, transferrin, thyroxin binding prealbumin (TBPA) and retinol binding protein (RBP). The authors report their own data, collected in 150 patients. Nearly all the patients' values are significantly lower than those of the controls; CHI, serum proteins and energy are related to the prognosis; most variables show significant interrelationship: TBPA and RBP are the most frequently decreased values.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6326224     DOI: 10.1016/0300-9572(84)90020-0

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  3 in total

1.  Serum albumin as a significant prognostic factor in patients with malignant pleural mesothelioma.

Authors:  Zhou-Hong Yao; Guang-Yan Tian; Shao-Xiang Yang; Yun-Yan Wan; Yan-Meng Kang; Qing-Hua Liu; Fei Yao; Dian-Jie Lin
Journal:  Tumour Biol       Date:  2014-04-15

Review 2.  Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature.

Authors:  Digant Gupta; Christopher G Lis
Journal:  Nutr J       Date:  2010-12-22       Impact factor: 3.271

3.  Can subjective global assessment of nutritional status predict survival in ovarian cancer?

Authors:  Digant Gupta; Carolyn A Lammersfeld; Pankaj G Vashi; Sadie L Dahlk; Christopher G Lis
Journal:  J Ovarian Res       Date:  2008-10-15       Impact factor: 4.234

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.